8YY Biolidics
- 0.010
- 0.0000.00%
Biolidics News
Biolidics Limited Confronts Cybersecurity Breach
Biolidics Appoints President
Biolidics (SGX:8YY) appointed Chen Lu as the company's new president and as a new executive director, effective April 30, according to a filing with the Singapore Exchange on Thursday. The appointment
Biolidics Ltd Announces Executive Board Reshuffle
Biolidics Ltd Announces Major Board Restructuring
Biolidics Appoints New Executive Director
Singapore Shares Fall at Market Close; Biolidics Up 9%
Singapore's Strait Times Index fell on Friday, following data released on economic growth and the central bank's decision to keep its monetary policy unchanged. During the day, the benchmark Singapore
Biolidics' Loss Narrows in 2023 as Revenue Slumps 47%; Shares Surge 9%
Biolidics (SGX:8YY) booked an attributable loss of SG$2.5 million for the year ended Dec. 31, 2023, compared with an attributable loss of SG$9.4 million in the year-ago period, according to the compan
Biolidics Ltd. Prepares for Executive Stock Issuance
Biolidics Ltd. Eyes Diversification Into Tech Lifestyle Sector
Biolidics to Issue Shares Worth Over SG$360,000 to New Director
Biolidics (SGX:8YY) will issue 33.5 million shares valued at SG$368,656 to a newly appointed executive director who will be supporting the strategic direction of the group's new technology-enabled ent
Biolidics Ltd Welcomes New Executive With Equity Stake
Biolidics Full Year 2023 Earnings: S$0.004 Loss per Share (Vs S$0.033 Loss in FY 2022)
Biolidics Issues Over 87 Million Shares to Sponsor, Investor
Biolidics (SGX:8YY) allotted and issued over 87 million shares on Thursday, which will be listed and quoted on the Singapore bourse on or about Jan. 15. Of these shares, 83 million shares were issued
Biolidics Obtains Bourse's Nod to List Over 87 Million Shares
Biolidics (SGX:8YY) obtained the Singapore Exchange's listing and quotation notice for over 87 million shares, according to a Monday filing. Of these shares, up to 83 million shares will be issued to
Biolidics to Issue SG$50,000 of Shares to Sponsor as Partial Payment of Professional Fee
Biolidics (SGX:8YY) will issue SG$50,000 worth of shares to its continuing sponsor, Evolve Capital Advisory, as partial payment of professional fees, according to a Thursday bourse filing. The medical
Biolidics to Raise Over SG$1 Million From Share Placement
Biolidics (SGX:8YY) will issue 83 million ordinary shares in the company to Zhou Chao, an independent Singaporean investor, at SG$0.0121 apiece or about SG$1 million. The shares represent 11.21% of th
Biolidics Ropes in Evolve Capital Advisory as Sponsor
Biolidics (SGX:8YY) has appointed Evolve Capital Advisory as its new sponsor, effective Dec. 21, replacing United Overseas Bank (SGX:U11). United Overseas Bank had informed the medical technology comp
Clearbridge Health Receives Full Amount of Outstanding Debt From Biolidics
Clearbridge Health (SGX:1H3) received the full amount of the final outstanding debt worth around SG$1.3 million from Biolidics (SGX:8YY) on Nov. 30. The debt was owed to Clearbridge BSA, a unit of Cle
Biolidics Issues 98.5 Million Shares Under Subscription Agreement; Shares Jump 8%
Biolidics (SGX:8YY) allotted and issued 98.5 million shares to a private individual for SG$0.01 each on Tuesday, Nov. 28, according to a same-day bourse filing. The medical technology company said the
Biolidics Obtains Regulatory Nod to List 98.5 Million Shares Under Subscription Agreement
Biolidics (SGX:8YY) obtained the approval from the Singapore Exchange for the listing and quotation of 98.5 million shares to be issued to a private individual under a subscription agreement. The medi
Analysis
Price Target
No Data
